Keros Therapeutics Inc (KROS) — Capital Reinvestment Ratio
Latest as of September 2025:
0.04x
Keros Therapeutics Inc (KROS) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow ($3.25 Million) in capital expenditures ($132.00K). See free cash flow generation of Keros Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$3.25 Million
USD
Capital Expenditures
$132.00K
USD
Data as of
Sep 2025
Most recent filing
Keros Therapeutics Inc Capital Reinvestment Ratio (2018–2018)
This chart tracks Keros Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Keros Therapeutics Inc (2018–2018)
Year-by-year Capital Reinvestment Ratio for Keros Therapeutics Inc from 2018 to 2018. For live market cap and broader valuation context, see Keros Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.03x | $7.04 Million | $217.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow